BRCA1 and BRCA2 pathogenic variants and prostate cancer risk: systematic review and meta-analysis.

These PCa risk estimates will assist in guiding clinical management. The study-level subgroup analyses indicate that risks may be modified by age and ethnicity, and for BRCA2 carriers by PV location within the gene, which may guide future risk-estimation studies.